Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00335517 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
98
Enrollment target

NCT00335517 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 98 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00335517, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target

Study Summary

The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.

Interventions

  • DRUG DepoDur

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2006-06
Est. Completion 2010-11
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT00335517

The ClinicalTrials.gov registry entry for NCT00335517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which DepoDur is the first listed.

NCT00335517 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00335517 about?

NCT00335517 is a clinical study titled "Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients". The purpose of the study is to help determine the appropriate dose of DepoDur for use in spinal surgery. The study will also assess the safety of this drug in this patient population.

What is the current status of trial NCT00335517?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2006-06. Estimated completion is 2010-11.

What interventions are being tested in trial NCT00335517?

The interventions under investigation include: DepoDur (DRUG).

Who is sponsoring clinical trial NCT00335517?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.